Dr. Neville is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
920 US-202 S
Raritan, NJ 08869
Education & Training
- Baylor College of MedicineFellowship, Pediatric Hematology/Oncology, 1998 - 2001
- Brown UniversityResidency, Pediatrics, 1995 - 1998
- State University of New York Downstate Medical Center College of MedicineClass of 1995
Certifications & Licensure
- AR State Medical License 2015 - 2024
- KS State Medical License 2005 - 2016
- MO State Medical License 2005 - 2016
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Fellow (FAAP) American Academy of Pediatrics
Clinical Trials
- Study of Nifurtimox to Treat Refractory or Relapsed Neuroblastoma or Medulloblastoma Start of enrollment: 2008 Jan 14
- External Beam Radiation Therapy and Cetuximab Followed by Irinotecan and Cetuximab for Children and Young Adults With Newly Diagnosed Diffuse Pontine Tumors and High-Grade Astrocytomas Start of enrollment: 2009 Oct 30
- Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors Start of enrollment: 2010 Nov 22
- Join now to see all
Publications & Presentations
PubMed
- 419 citationsThree new datasets supporting use of the Numerical Rating Scale (NRS-11) for children's self-reports of pain intensity.Carl L. von Baeyer, Lara J. Spagrud, Julia C. McCormick, Eugene Choo, Kathleen A. Neville
Pain. 2009-06-01 - 107 citationsA Phase I Trial of DFMO Targeting Polyamine Addiction in Patients with Relapsed/Refractory Neuroblastoma.Giselle Saulnier Sholler, Eugene W. Gerner, Genevieve Bergendahl, Robert B. MacArthur, Alyssa VanderWerff
Plos One. 2015-05-27 - 23 citationsCandidate Sequence Variants and Fetal Hemoglobin in Children with Sickle Cell Disease Treated with HydroxyureaNancy S. Green, Katherine L. Ender, Farzana Pashankar, Catherine Driscoll, Patricia J. Giardina
Plos One. 2013-02-07
Press Mentions
- Pediatric Labeling for OxyContin: Pros & ConsSeptember 1st, 2016
- F.D.A. Approval of OxyContin for Children Continues to Draw ScrutinyJanuary 13th, 2016
Grant Support
- Pharmacogenetics Of Pediatric Sickle Cell DiseaseNational Heart, Lung, And Blood Institute2006–2010
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: